1. Home
  2. Analysis

Irritable bowel syndrome and drugs of ingredients of acamprosate calcium - a phase IV clinical study of FDA data


Summary:

Irritable bowel syndrome is reported only by a few people who take drugs with ingredients of acamprosate calcium. This phase IV clinical study analyzes 1,626 people who have side effects while taking drugs with ingredients of acamprosate calcium from the the FDA. Among them, 4 have Irritable bowel syndrome. Find out below who they are, when they have Irritable bowel syndrome and more.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Acamprosate calcium, Campral.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jun, 01, 2023

1,626 people reported to have side effects when taking drugs with ingredients of acamprosate calcium.
Among them, 4 people (0.25%) have Irritable bowel syndrome

What is Irritable bowel syndrome?

Irritable bowel syndrome is found to be associated with 2,640 drugs and 2,049 conditions by eHealthMe.

Number of reports submitted per year:

Could drugs with ingredients of acamprosate calcium cause Irritable bowel syndrome?

Gender of people who have Irritable bowel syndrome when taking drugs with ingredients of acamprosate calcium *:

  • female: 0.0 %
  • male: 100 %

Conditions people have *:

  1. Lipid Metabolism Disorder (genetic disorders are caused by errors in fatty acid metabolism): 3 people, 75.00%
  2. Stress And Anxiety: 1 person, 25.00%
  3. Obsessive-Compulsive Disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;): 1 person, 25.00%
  4. Depression: 1 person, 25.00%
  5. Anger: 1 person, 25.00%
  6. Acne (skin problems that cause pimples): 1 person, 25.00%

Other drugs people take *:

  1. Vitamin D3: 3 people, 75.00%
  2. Singulair: 3 people, 75.00%
  3. Proair Hfa: 3 people, 75.00%
  4. Kanuma: 3 people, 75.00%
  5. Heparin: 3 people, 75.00%
  6. Advair Hfa: 3 people, 75.00%
  7. Invega Sustenna: 1 person, 25.00%
  8. Invega: 1 person, 25.00%
  9. Cogentin: 1 person, 25.00%
  10. Accutane: 1 person, 25.00%

Other side effects people have besides Irritable bowel syndrome *:

  1. Haemorrhoids (a swollen vein or group of veins in the region of the anus): 3 people, 75.00%
  2. Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 3 people, 75.00%
  3. Headache (pain in head): 3 people, 75.00%
  4. Injection Site Pain: 3 people, 75.00%
  5. Cough: 3 people, 75.00%
  6. Neck Pain: 3 people, 75.00%
  7. Haematochezia (passage of stools containing blood): 2 people, 50.00%
  8. Dizziness: 2 people, 50.00%
  9. Pancreatitis (inflammation of pancreas): 1 person, 25.00%
  10. Inflammatory Bowel Disease: 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drugs with ingredients of acamprosate calcium, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on acamprosate calcium. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.